Clinical trial

Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat…

NCT00052962 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00052962
Title Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis
Official title A Prospective Random Assignment Trial to Study Operative Debulking and Systemic Chemotherapy With or Without Intra-and Peri-Operative Intraperitoneal Chemotherapy for Subjects With Peritoneal Carcinomatosis From Low Grade Gastrointestinal Adenocarcinoma
Lead sponsor National Cancer Institute (NCI), NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Gastrointestinal Neoplasm
Intervention type Procedure
Interventions Cytoreductive surgery, Continuous hyperthermic peritoneal perfusion (HIPEC/CHPP)
Enrollment 30
Start date Jan 1, 2003
Primary completion Sep 1, 2008
Completion Sep 1, 2008
First posted Jan 27, 2003
Last update posted Nov 22, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies